In a preclinical murine setting, combining an adenovirus encoding IL-2 and TNF with TILs showed increased antitumor efficacy in comparison to single-agent treatment with virus therapy or TIL therapy in melanoma.10 This evidence concerns the gene IL2 and melanoma.